Evidence map›Paper›PMID 31992604›Full record

ArticleBMJ open2020

Is telehealthcare for heart failure patients cost-effective? An economic evaluation alongside the Danish TeleCare North heart failure trial.

Anne Sig Vestergaard, Louise Hansen, Sabrina Storgaard Sørensen, Morten Berg Jensen, Lars Holger Ehlers

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02860013 (Effectiveness and Cost-effectiveness of Telemedicine for Heart Failure), which is not on this map. Cited by 29 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 6 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02860013 nacompletednot on this map

Effectiveness and Cost-effectiveness of Telemedicine for Heart Failure: The Danish "TeleCare North" Pragmatic Randomized Trial

TypeinterventionalSponsorAalborg UniversityRan2016 to 2018Enrolled600ConditionsHeart FailureArmsTelemedicine
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 6 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Home-based versus centre-based cardiac rehabilitation.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anne Sig VestergaardDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, Denmark.ORCID 0000-0001-9769-1490
Louise HansenDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, Denmark.ORCID 0000-0002-4400-2732
Sabrina Storgaard SørensenDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, Denmark.ORCID 0000-0002-6048-521X
Morten Berg JensenAarhus Business School, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-9455-0104
Lars Holger EhlersDanish Center for Healthcare Improvements, Department of Business and Management, Aalborg University, Aalborg Oest, Denmark lehlers@dcm.aau.dk.ORCID 0000-0002-9521-9931
Aalborg University · DKAarhus University · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to assess the cost-effectiveness of telehealthcare in heart failure patients as add-on to usual care.

designA cost-utility analysis was conducted from a public payer perspective alongside the randomised controlled TeleCare North trial.

settingThe North Denmark Region, Denmark.

participantsThe study included 274 heart failure patients with self-reported New York Heart Association class II-IV.

interventionsPatients in the intervention group were provided with a Telekit consisting of a tablet, a digital blood pressure monitor, and a scale and were instructed to perform measurements one to two times a week. The responsibility of the education, instructions and monitoring of the heart failure (HF) patients was placed on municipality nurses trained in HF and telemonitoring. Both groups received usual care. OUTCOME MEASURES: Cost-effectiveness was reported as incremental net monetary benefit (NMB). A micro-costing approach was applied to evaluate the derived savings in the first year in the public health sector. Quality-adjusted life-years (QALY) gained were estimated using the EuroQol 5-Dimensions 5-Levels questionnaire at baseline and at a 1-year follow-up.

resultsData for 274 patients were included in the main analysis. The telehealthcare solution provided a positive incremental NMB of £5164. The 1-year adjusted QALY difference between the telehealthcare solution and the usual care group was 0.0034 (95% CI: -0.0711 to 0.0780). The adjusted difference in costs was -£5096 (95% CI: -8736 to -1456) corresponding to a reduction in total healthcare costs by 35%. All sensitivity analyses showed the main results were robust.

conclusionsThe TeleCare North solution for monitoring HF was highly cost-effective. There were significant cost savings on hospitalisations, primary care contacts and total costs. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov: NCT02860013.

Indexed as

Computers, HandheldCost-Benefit AnalysisDenmarkHealth StatusHeart FailureHumansMonitoring, AmbulatoryQuality-Adjusted Life YearsQuality of LifeSeverity of Illness IndexTelemedicinehealth economicshealth informaticsheart failuretelemedicine

Identifiers

PMID31992604
PMCPMC7045102
OpenAlexW3003510979

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.